# Mount Logan Capital Inc.: overview

MLCI · Nasdaq · CIK 2051820 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mlci.md) · [Financials](/companies/mlci/financials.md) · [Filings](/companies/mlci/filings.md) · [Insiders](/companies/mlci/insiders.md)

Latest reported revenue: [$8.7m](/filings/0001628280-26-055789.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-055789).

## Last eight quarters

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [12.7](/filings/0002051820-25-000137.md) | [9.0 d](/filings/0002051820-26-000039.md) | [15.1](/filings/0001628280-26-035167.md) | [17.1](/filings/0001628280-26-055789.md) | [11.4](/filings/0002051820-25-000137.md) | [9.9 d](/filings/0002051820-26-000039.md) | [10.6](/filings/0001628280-26-035167.md) | [8.7](/filings/0001628280-26-055789.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(19.1%)](/filings/0002051820-25-000137.md) | [(88.7%) d](/filings/0002051820-26-000039.md) | [(44.6%)](/filings/0001628280-26-035167.md) | [(5.5%)](/filings/0001628280-26-055789.md) | [(117.5%)](/filings/0002051820-25-000137.md) | [(399.8%) d](/filings/0002051820-26-000039.md) | [(56.1%)](/filings/0001628280-26-035167.md) | [(47.8%)](/filings/0001628280-26-055789.md) |
| Diluted EPS | $ per share | [(0.40)](/filings/0002051820-25-000137.md) | not reported | [(1.02)](/filings/0001628280-26-035167.md) | [(0.14)](/filings/0001628280-26-055789.md) | [(1.64)](/filings/0002051820-25-000137.md) | not reported | [(0.51)](/filings/0001628280-26-035167.md) | [(0.37)](/filings/0001628280-26-055789.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: |
| Revenue | $m | [49.8](/filings/0002051820-26-000039.md) | [53.6](/filings/0002051820-26-000039.md) |
| Gross margin | % | not reported | not reported |
| Operating margin | % | not reported | not reported |
| Net margin | % | [(20.9%)](/filings/0002051820-26-000039.md) | [(113.6%)](/filings/0002051820-26-000039.md) |
| Diluted EPS | $ per share | [(1.70)](/filings/0002051820-26-000039.md) | [(7.08)](/filings/0002051820-26-000039.md) |
| Free cash flow | $m | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mlci/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.1m | 596,446 |  | Reduced −452 |
| [JB CAPITAL PARTNERS LP](/funds/1138532.md) | 2026-06-30 | $1.8m | 534,729 |  | Added +31,049 |
| [HighTower Advisors, LLC](/funds/1462245.md) | 2026-06-30 | $985.2k | 286,393 |  | Added +5,069 |
| [FIL Ltd](/funds/318989.md) | 2026-06-30 | $679.0k | 197,397 |  | Unchanged |
| [PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.](/funds/1238990.md) | 2026-06-30 | $635.0k | 184,592 |  | Reduced −34,312 |
| [FINANCIAL CONSULATE, INC](/funds/1624510.md) | 2026-06-30 | $569.1k | 165,445 |  | Reduced −9,512 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $350.2k | 101,804 |  | Added +5,989 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $273.5k | 79,515 |  | Added +32,051 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $261.2k | 75,927 |  | Reduced −9,751 |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $260.5k | 75,715 |  | Added +452 |

## Recent filings

[All 146 filings](/companies/mlci/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 12:05 ET | [8-K](/filings/0001628280-26-066397.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-066397 |
| 2026-10-15 | 21:21 ET | [8-K](/filings/0001628280-26-066021.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001628280-26-066021 |
| 2026-08-11 | 21:05 ET | [10-Q](/filings/0001628280-26-055789.md) | Quarterly report, period 2026-06-30 | 0001628280-26-055789 |
| 2026-08-11 | 21:05 ET | [8-K](/filings/0001628280-26-055790.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-055790 |
| 2026-06-26 | 21:25 ET | [8-K](/filings/0001628280-26-045830.md) | 5.07 Shareholder vote results | 0001628280-26-045830 |
| 2026-05-14 | 20:54 ET | [8-K](/filings/0001628280-26-035188.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-035188 |
| 2026-05-14 | 20:44 ET | [10-Q](/filings/0001628280-26-035167.md) | Quarterly report, period 2026-03-31 | 0001628280-26-035167 |
| 2026-04-29 | 20:22 ET | [DEF 14A](/filings/0001193125-26-191732.md) | Proxy statement, period 2026-06-25 | 0001193125-26-191732 |
| 2026-04-15 | 11:37 ET | [8-K](/filings/0001628280-26-025152.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-025152 |
| 2026-04-13 | 20:11 ET | [8-K](/filings/0001628280-26-024890.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-024890 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0002051820-26-000039.md), filed Mar 19, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/b55a47c1-898c-44d4-93cd-b8caa16d2c3f)

## About the filer

- CIK: 2051820
- Tickers: MLCI, MLCIL
- Exchange: Nasdaq
- SIC code: 6282 Investment Advice
- State of incorporation: DE
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.